Literature DB >> 18641607

Detection of myocardial disorders by magnetic resonance spectroscopy.

Lucy E Hudsmith1, Stefan Neubauer.   

Abstract

Magnetic resonance spectroscopy (MRS) utilizes magnetic resonance signals from nuclei, such as phosphorus-31, to provide information regarding the biochemical composition and metabolic state of cardiac muscle. This technique is the only method available for noninvasive assessment of cardiac metabolism without the need for the application of external radioactive tracers. MRS provides insights into the role of cardiac energetics in ischemic heart disease, heart failure, hypertrophy, and valve disease. Furthermore, response to therapeutic intervention can be monitored using this method. At present, this technique is used as a research tool, because low spatial and temporal resolution, as well as low reproducibility, precludes its diagnostic use in clinical practice; however, higher-field magnetic resonance systems-using, for example, 7 T-will enable improvements in resolution and reproducibility that may take cardiac MRS into the clinical realm.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641607     DOI: 10.1038/ncpcardio1158

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  9 in total

1.  Delayed Myocardial Enhancement in Pediatric Hypertrophic Cardiomyopathy: Correlation with LV Function, Echocardiography, and Demographic Parameters.

Authors:  Sonia El Saiedi; Noha Hossam Behairy; Ahmed Kharabish; Reem Esmail; Zeinab Salah Seliem; Mervat Shafik; Wesam El Mozy
Journal:  Pediatr Cardiol       Date:  2017-04-11       Impact factor: 1.655

Review 2.  Phase II trials in heart failure: the role of cardiovascular imaging.

Authors:  Sanjiv J Shah; Gregg C Fonarow; Mihai Gheorghiade; Roberto M Lang
Journal:  Am Heart J       Date:  2011-07       Impact factor: 4.749

3.  Cardiac MRI for Patients with Increased Cardiometabolic Risk.

Authors:  Cynthia Philip; Rebecca Seifried; P Gabriel Peterson; Robert Liotta; Kevin Steel; Marcio S Bittencourt; Edward A Hulten
Journal:  Radiol Cardiothorac Imaging       Date:  2021-04-01

Review 4.  Imaging and modeling of myocardial metabolism.

Authors:  Sebastian Obrzut; Neema Jamshidi; Afshin Karimi; Ulrika Birgersdotter-Green; Carl Hoh
Journal:  J Cardiovasc Transl Res       Date:  2010-02-25       Impact factor: 4.132

5.  Reproducibility of creatine kinase reaction kinetics in human heart: a (31) P time-dependent saturation transfer spectroscopy study.

Authors:  Adil Bashir; Robert Gropler
Journal:  NMR Biomed       Date:  2014-04-06       Impact factor: 4.044

6.  Human cardiac 31P magnetic resonance spectroscopy at 7 Tesla.

Authors:  Christopher T Rodgers; William T Clarke; Carl Snyder; J Thomas Vaughan; Stefan Neubauer; Matthew D Robson
Journal:  Magn Reson Med       Date:  2013-09-04       Impact factor: 4.668

7.  Reproducibility of human cardiac phosphorus MRS (31 P-MRS) at 7 T.

Authors:  Jane Ellis; Ladislav Valkovič; Lucian A B Purvis; William T Clarke; Christopher T Rodgers
Journal:  NMR Biomed       Date:  2019-03-29       Impact factor: 4.044

8.  Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case-control study.

Authors:  Miroslawa Gorecka; Nicholas Jex; Sharmaine Thirunavukarasu; Amrit Chowdhary; Joanna Corrado; Jennifer Davison; Rachel Tarrant; Ana-Maria Poenar; Noor Sharrack; Amy Parkin; Manoj Sivan; Peter P Swoboda; Hui Xue; Vassilios Vassiliou; Peter Kellman; Sven Plein; Stephen J Halpin; Alexander D Simms; John P Greenwood; Eylem Levelt
Journal:  J Cardiovasc Magn Reson       Date:  2022-09-12       Impact factor: 6.903

9.  Bloch-Siegert B1+-mapping for human cardiac (31) P-MRS at 7 Tesla.

Authors:  William T Clarke; Matthew D Robson; Christopher T Rodgers
Journal:  Magn Reson Med       Date:  2015-10-28       Impact factor: 4.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.